AEGiS-PRn: AHF Lauds Schwarzenegger's Work on AIDS Issues During First Year PRNewswireImportant note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
Click here to return to PRNewswire main menu
DonateNow


AHF Lauds Schwarzenegger's Work on AIDS Issues During First Year

PRNewswire - October 26, 2004


-- The Nation's Largest AIDS Organization Gives Schwarzenegger a Good Grade for His Work on AIDS Issues

LOS ANGELES, Oct. 26 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the largest AIDS organization in the US, which treats nearly 6,000 Californians living with HIV, applauds the efforts of Governor Schwarzenegger, during his first year in office, in fighting for the rights of people living with HIV and AIDS. Since beginning his term nearly one-year ago, the Governor has taken favorable action on a number of items that will benefit both the prevention and treatment of HIV/AIDS throughout California.

As one of his first actions in office, Governor Schwarzenegger signed AB 685 (Leno, D, San Francisco) into law. This piece of legislation, sponsored by AIDS Healthcare Foundation, is a cost saving measure intended to jumpstart stalled rapid HIV testing programs by streamlining training for HIV testing counselors. "Getting people tested and into treatment is a crucial step in addressing HIV/AIDS as a public health issue," said Karen Mall, Director of Prevention and Testing for AHF. "AB 685 will allow for HIV testing counselors to receive comprehensive training without the bureaucratic red tape that currently surrounds the system. The new requirements under this law will increase the accessibility and ease of rapid-HIV counseling and testing for all Californians."

In the Governor's 'May Revise' of the budget, he took two important steps to help guarantee access to quality medical treatment for Californians living with HIV/AIDS. The Governor increased the budget for the state's AIDS Drug Assistance Program (ADAP) by 13%, adding an additional $27 million to the program. This budget supplement came at the demand of AIDS advocates from around the state who protested the proposed enrollment cap to the program.

Governor Schwarzenegger heard the concerns of the advocates, and took the issue off the table -- ensuring that California, despite financial hardships, would protect essential programs for HIV/AIDS treatment. In addition, the governor agreed to $4 million specifically earmarked for viral load and HIV resistance testing. Last year, $7 million was cut from the $8 million Therapeutic Monitoring Program (TMP) budget. The 300% increase approved by the Governor ensures that all patients enrolled in ADAP will have their drug regimens closely monitored by diagnostic tests to make certain that the their regimens are working and the care that they receive is the most effective.

At the end of this year's legislative session, Governor Schwarzenegger signed two important bills into law that will have an impact on HIV/AIDS in California. SB 1159 (Vasconsellos, D, Santa Clara), which creates a disease prevention demonstration project allowing individuals to purchase up to 10 hypodermic needles and syringes without a prescription; and AB 1367 (Steinberg/Laird), co-sponsored by AHF, which creates a pilot project for AIDS pharmacies to provide additional medication management services for people living with HIV/AIDS in California; the measure allocates up to $1.5 million to pay for these extra services. "By signing the syringe bill (SB 1159), a controversial yet, pragmatic public health measure, the governor illustrates his aim to try and reduce the spread of infectious diseases like HIV and Hepatitis C," said Jessie Gruttadauria, Associate Director of Government Affairs, California for AIDS Healthcare Foundation. "And with signing of the pharmacy bill (AB 1367), the governor acknowledges that specialized care for people living with HIV -- though a costly process that involves more time and attention from care providers -- is crucial and indispensable to the patients' well-being."

Michael Weinstein, President of AHF, went onto say, "although we are encouraged by a number of the Governor's actions this year with respect to HIV/AIDS issues, we want to let him know that there is still a lot of work to be done. Prices for prescription drugs are still much too high, and he chose to veto all of the importation bills that would have allowed Californians to access cheaper drugs from Canada. There is a serious problem with the drug companies' lack of transparency with respect to drug pricing and rebates. There are still a lot of issues to be taken up at the state level, and we look forward to working with the Governor in the year ahead to ensure access to quality healthcare for all those living with HIV/AIDS."

SOURCE AIDS Healthcare Foundation


041026
PR041036


Copyright © 2004 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019  http://www.prnewswire.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .